Parabilis Medicines, Inc. Deferred Offering Costs
Parabilis Medicines, Inc. (PBLS) had Deferred Offering Costs of $5.40 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredOfferingCosts · last filed 2026-08-13
- 2026-06-30: Deferred Offering Costs $5.40M.
- 2025-12-31: Deferred Offering Costs $600.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2026-06-30 | $5.40M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $600.00K 10-Q · filed 2026-08-13 |